Skip to main content
. 2017 Oct 30;4:180. doi: 10.3389/fmed.2017.00180

Table 1.

Change in biomarker plasma concentrations.

Metformin (N = 35) Placebo (N = 42) p-value
Total cholesterol 12.6 (−114 to 175) 17.1 (−294 to 143) 0.762
High-density lipoproteins −2.3 (−25 to 39) −7.5 (−40 to 14) 0.019
Oxidized low-density lipoproteins −12.2 (−70 to 33) −3.8 (−53 to 71) 0.038
Glucose −9.2 (−85 to 58) −4.2 (−50 to 33) 0.847
Insulin 1.8 (−850 to 1,382) −100.2 (−910 to 343) 0.075
Unacylated Ghrelin 50.6 (−156 to 1,437) 51.8 (−202 to 650) 0.299
Leptin 12.4 (−17 to 33) 9.25 (−14 to 83) 0.339

Data presented as median (range).